The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched last November 18 to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.
Antibiotics and other antimicrobials play a key role in the success of modern medicine and have greatly improved the health of humans and animals. But overuse and misuse have reduced their efficacy, with more pathogens developing the ability to survive the antimicrobials designed to eliminate them. The new Antimicrobial Resistance Multi-Stakeholder Partnership Platform is an inclusive and international forum bringing together voices from all areas, sectors and perspectives through a holistic and system-wide One Health approach, for a shared vision responding to the need to improve coordination of efforts by a large number of stakeholders.